In utilizing the drug or medication units described herein for the treatment of both malignant and non-malignant tumors by targeting nuclides to the sites thereof with antibodies such as monoclonal antibodies produced to target to specific antigens such as the cells of the tumor and/or an organ in which the tumor exists, or in the treatment of other maladies, such as a disease characterized by a l